Cholamandalam Investment & Finance Company Ltd
CHOLAFINCholamandalam Investment & Finance Company Ltd compounds quietly. Returns above 15% and growth without drama — priced like it.
The sharpest disagreement: Foreign institutions moved −2.2 points over 8 quarters while the operating story went the other way — someone close to the numbers is not convinced.
The price is in a confirmed uptrend (5 weeks in) while the P/BV sits at the 61st percentile of its own 10-year range. Underneath, the last four quarters read improving — profit +45.5% year on year, with the the net margin at 18.7%. What settles it: whether the register turns back in the story’s favour.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Cholamandalam Investment & Finance Company Ltd trades at ₹1,850, in a confirmed uptrend and 5 weeks into that stage. That is +13.2% against its own 200-day average. It sits at 100% of a 52-week range of ₹1,416 to ₹1,850. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 11 straight weeks.
Today the stock is in a confirmed uptrend — week 5 of stage 2, confirmed. At ₹1,850 it trades +13.2% versus its 200-day average and sits at 100% of its 52-week range (₹1,416–₹1,850).
Against the market, two honest reads. Cumulative: over the last 10.4 years the stock moved +1,280% while the NIFTY 500 moved +276% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 11 straight weeks — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation For a bank we price the book, not the earnings: P/BV is what the market pays for each ₹1 of the bank's net worth. A bank below 1× book is priced below the value of what it owns, net of what it owes.
Cholamandalam Investment & Finance Company Ltd trades at 5.2× P/BV, mid-range by its own standards (61st percentile). Its long-run median P/BV is 4.7×, measured across 10.4 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/BV of 5.2× is mid-range by its own standards (61st percentile), against a long-run median of 4.7× measured over 10.4 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
Why the multiple sits where it does: over the past year book value grew while the price moved +30.0% — price and book moved together, holding the multiple in its range.
The price move, decomposed: over 5y, of the +31.2%/yr price move, ~+25.1%/yr came from book-value growth and ~+6.1 pp from the multiple (expanding); over 10y, of the +23.8%/yr price move, ~+22.6%/yr came from book-value growth and ~+1.2 pp from the multiple (expanding). The split is the honest approximate (price return minus book-value growth); it makes the rally itself visible instead of hiding it behind the percentile.
Put together: the multiple is unremarkable against its own past, so the story rests on the book-value line underneath it, not the multiple.
Stage: Consistent Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Cholamandalam Investment & Finance Company Ltd reads as consistent on its fundamental arc. Consistent — revenue, profit and EPS growth have stayed positive through the window, with ROE at 18.9% and holding. The read is built from 11 quarters across 4 curves, on full evidence.
Why it matters: steady curves with healthy returns are the compounding setup — the risk is the price, not the business.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | +20.2% | +34.2% | +26.6% | +22.1% |
| Profit | +22.8% | +25.2% | +28.0% | +24.7% |
| EPS | +21.1% | +23.7% | +27.1% | +23.6% |
| Share price | +30.0% | +17.6% | +31.2% | +23.8% |
4-Factor Sector Score
59.8/100 — rank 1 of 8 in Conglomerate Backed NBFC · 82% evidence confidence
Cholamandalam Investment & Finance Company Ltd scores 59.8 out of 100 against the 8 companies it is compared with in Conglomerate Backed NBFC, ranking 1. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.
The four contributions add to the total exactly: 23.9 + 18.7 + 7.7 + 9.5 = 59.8. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.
What would change it: The read weakens if ROA rolls over or gross NPA rises while sector-relative strength deteriorates.
Revenue For a bank, revenue is everything the franchise earns — interest on the loan book plus fee and other income.
Cholamandalam Investment & Finance Company Ltd reported ₹8,856 Cr of income in the Jun 26 quarter, +21.9% year on year. That is the 11th straight quarter of year-on-year growth. Over 10 years it has compounded at 22.1% a year. The last full year, FY26, came in at ₹31,120 Cr. The last four reported quarters add to ₹32,662 Cr.
FY26 revenue came in at ₹31,120 Cr (+20.2% on the year), capping 10 years at 22.1% compound. The latest quarter (Jun 26) printed ₹8,856 Cr, +21.9% year on year — the 11th consecutive quarter of year-over-year growth.
Pace check: the last four quarters averaged +19.6% growth against the decade's 22.1% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew +19.6% over the last 4 quarters against +25.2%/yr over the last 8 — rolling over; TTM profit +29.1% vs +25.4%/yr — accelerating.
Net margin Net margin — what the bank keeps of every ₹100 of revenue after every cost, provision and tax. It is the cleanest single margin we can read for a lender.
Cholamandalam Investment & Finance Company Ltd's net margin is 18.7% in the Jun 26 quarter, +3.0 percentage points against the same quarter a year ago. Across 13 fiscal years the net margin has ranged 11.2% to 21.2%. The current quarter sits inside that band.
The latest quarter's net margin is 18.7%, +3.0 pp against the same quarter a year ago. Across 13 fiscal years the net margin has ranged 11.2%–21.2%.
Why: the numbers show the net margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Cholamandalam Investment & Finance Company Ltd earned ₹1,656 Cr of net profit in the Jun 26 quarter, +45.5% year on year. It is the 11th consecutive quarter of growth. Full-year FY26 profit was ₹5,233 Cr. The 10-year compound rate is 24.7%. That is 18.7% of the quarter's revenue. The same quarter a year earlier earned ₹1,138 Cr.
Jun 26 profit was ₹1,656 Cr, +45.5% year on year — the 11th consecutive quarter of growth. On the full year, FY26 printed ₹5,233 Cr (+22.8%), and the 10-year compound rate is 24.7%.
Why profit moved: revenue contributed +21.9% and the margin +3.0 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.
Pace comparison, last four quarters: profit +28.6% vs revenue +19.6%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.
Asset quality — the ladder Gross NPA is the slice of the loan book where repayments have stopped. Net NPA is what remains after the money already set aside against those loans. Falling is healing; rising is damage arriving.
Loan-book quality history is not available for Cholamandalam Investment & Finance Company Ltd, so this section names the gap rather than estimating a ratio. No gross or net non-performing-asset series is filed in a form this page can read, and none is inferred from the profit line.
We do not hold quarterly loan-book quality numbers for this bank, so this section states that plainly rather than working around it.
Why: loan-book quality is the engine room of a bank, and its drivers — slippages, recoveries, provisioning — sit below what we hold for this name; the sections around it carry the reads we can stand behind.
The loan book We read the loan book through revenue — when the book grows, revenue grows with it. It is a rough proxy, and we say so: rate moves and fee swings can shift it a few points in any one year.
Cholamandalam Investment & Finance Company Ltd's revenue grew +20.2% in FY26 to ₹31,120 Cr, so the book is growing. The latest quarter ran +21.9% year on year. The net margin on that income is 18.7%, +3.0 percentage points against a year ago.
FY26 revenue was ₹31,120 Cr, +20.2% on the year, and the latest quarter ran +21.9% year on year. The net margin on that revenue is 18.7% this quarter (+3.0 pp YoY) — growth with a widening margin on it.
The synthesis: a lender compounds when the book grows while the margin holds and the loan book stays clean — gross NPA is the loan-quality read we carry here.
Returns on equity and assets Two numbers rate a bank: ROE — what it earns on shareholder money — and ROA — what it earns on everything it deploys. ROE above ~13–15% earns its keep; below that, growth builds book slowly.
Cholamandalam Investment & Finance Company Ltd earns a return on equity of 19% in FY26. Its trough over the ladder below was 15% in FY20. For a lender the balance sheet is the operating asset, so equity return and asset return have to be read together.
FY26 ROE came in at 19%, recovered from a FY20 trough of 15%. On assets, the latest reading is about null% — every ₹100 the bank deploys earns roughly null a year. That clears the bar a bank must beat for its book value to compound.
Why ROE moved: profit compounded 24.7% a year over 10 years while the equity base grew more slowly — earnings recovering faster than book value builds is what lifts ROE off a trough.
Debt
For a bank, borrowings are raw material, not a warning sign — solvency is read through the returns and the loan book. A manufacturer’s debt is a claim against its profits, so the debt-to-equity lens that works everywhere else misleads on a lender and is not applied here.
A manufacturer’s debt is a claim against its profits; a bank’s borrowings are its inventory — money taken in to be lent out. The debt lens that works everywhere else misleads here, so this page does not apply it. The solvency questions for a bank — is the loan book sound, is the equity earning — are read through the loan-book and returns sections above.
Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.
Domestic institutions added 3.8 points of Cholamandalam Investment & Finance Company Ltd over 8 quarters, the biggest move on the register. That takes domestic institutions to 20.6% of the company. Foreign institutions moved −2.2 points over the same window, to 24.5%. The register is read on the four disclosed classes only; nothing is inferred between filings.
The register over the last two years — Domestic institutions: +3.8 points over 8 quarters to 20.6%; Foreign institutions: −2.2 points over 8 quarters to 24.5%; Promoters: −1.1 points over 8 quarters to 49.2%.
Why the register moved: rotation — foreign institutions −2.2 points against domestic institutions +3.8 points over 8 quarters, with promoters −1.1 points — one class of institutions handing the register to the other, not a verdict change by the people closest to the numbers.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Cholamandalam Investment & Finance Company Ltd: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre. The Z-score was built for manufacturers and is not applied to banks and lenders, so solvency here is read from the capital and asset-quality lines instead.
The safety line in one sentence: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre.
| Company | Score | Price stage | Growth & earnings/35 | Capital efficiency/25 | Valuation/20 | Relative strength/20 |
|---|---|---|---|---|---|---|
| 1Cholamandalam Investment & Finance Company Ltdthis pageCHOLAFIN | 59.8/100Mixed-positive evidence82% evidence | TURNING | 23.9/35 Income 19.6% · PAT 29.1% 86% evidence | 18.7/25 ROA 2.1% · ROE 19.4% · GNPA — 72% evidence | 7.7/20 P/BV 5.18× · P/BV÷ROE 0.27 100% evidence | 9.5/20 RS sector -8.7% · RS bench 11.9% · 1Y 23%5 of 10 weeks ahead 70% evidence |
| Exact sum: 23.9 + 18.7 + 7.7 + 9.5 = 59.8 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 2HDB Financial Services LtdHDBFS | 56.9/100Mixed-positive evidence65% evidence | TURNING | 19.8/35 Income 12% · PAT 27.7% 81% evidence | 16.5/25 ROA 2.1% · ROE 14.7% · GNPA — 68% evidence | 12.6/20 P/BV 2.73× · P/BV÷ROE 0.19 70% evidence | 8.0/20 RS sector — · RS bench -5.5% · 1Y -9.8%2 of 10 weeks ahead 25% evidence |
| Exact sum: 19.8 + 16.5 + 12.6 + 8 = 56.9 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 3Poonawalla Fincorp LtdPOONAWALLA | 52.0/100Mixed-positive evidence70% evidence | BREAKING OUT | 27.2/35 Income 72.5% · PAT 100% 62% evidence | 10.2/25 ROA — · ROE 5.9% · GNPA — 34% evidence | 3.9/20 P/BV 3.65× · P/BV÷ROE 0.62 100% evidence | 10.7/20 RS sector -5.8% · RS bench 2% · 1Y 11.9%5 of 12 weeks ahead 100% evidence |
| Exact sum: 27.2 + 10.2 + 3.9 + 10.7 = 52 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 4Bajaj Finance LtdBAJFINANCE | 51.8/100Mixed-positive evidence87% evidence | TURNING | 16.6/35 Income 17.9% · PAT 17.1% 100% evidence | 20.4/25 ROA 3.5% · ROE 18.2% · GNPA — 72% evidence | 5.8/20 P/BV 6.23× · P/BV÷ROE 0.34 100% evidence | 9.0/20 RS sector -8.8% · RS bench 16.2% · 1Y 24.9%4 of 10 weeks ahead 70% evidence |
| Exact sum: 16.6 + 20.4 + 5.8 + 9 = 51.8 · Decision use: Strong business, demanding price: keep it on the quality list, but require either earnings upgrades or valuation compression. | ||||||
| 5L&T Finance LtdLTF | 48.4/100Mixed-negative evidence88% evidence | BREAKING OUT | 15.5/35 Income 15.2% · PAT 20.2% 86% evidence | 14.7/25 ROA 2.1% · ROE 11.2% · GNPA — 72% evidence | 7.8/20 P/BV 2.78× · P/BV÷ROE 0.25 100% evidence | 10.4/20 RS sector 2.4% · RS bench 10.5% · 1Y 51.9%5 of 12 weeks ahead 100% evidence |
| Exact sum: 15.5 + 14.7 + 7.8 + 10.4 = 48.4 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 6Aditya Birla Capital LtdABCAPITAL | 48.1/100Mixed-negative evidence88% evidence | LEADER | 15.5/35 Income 16.3% · PAT 18.2% 86% evidence | 11.5/25 ROA 1.1% · ROE 12% · GNPA — 72% evidence | 5.9/20 P/BV 3.08× · P/BV÷ROE 0.26 100% evidence | 15.2/20 RS sector 9.4% · RS bench 18% · 1Y 55.3%11 of 12 weeks ahead 100% evidence |
| Exact sum: 15.5 + 11.5 + 5.9 + 15.2 = 48.1 · Decision use: Price leads the evidence: RS versus the benchmark is 18%, but earnings trajectory is weak. Wait for revenue and profit confirmation. | ||||||
| 7Piramal Finance LtdPIRAMALFIN | 43.0/100Mixed-negative evidence61% evidence | FADING | 23.2/35 Income 17.8% · PAT 100% 52% evidence | 8.6/25 ROA — · ROE 0.9% · GNPA — 34% evidence | 3.2/20 P/BV 1.66× · P/BV÷ROE 1.93 100% evidence | 8.0/20 RS sector -44.5% · RS bench 46.5% · 1Y —10 of 12 weeks ahead 70% evidence |
| Exact sum: 23.2 + 8.6 + 3.2 + 8 = 43 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
| 8Jio Financial Services LtdJIOFIN | 33.1/100Adverse evidence82% evidence | TURNING | 18.3/35 Income 100% · PAT 27.1% 86% evidence | 6.9/25 ROA 1% · ROE 1.2% · GNPA — 72% evidence | 3.9/20 P/BV 1.21× · P/BV÷ROE 1.02 100% evidence | 4.0/20 RS sector -16.8% · RS bench -7.2% · 1Y -17.6%0 of 10 weeks ahead 70% evidence |
| Exact sum: 18.3 + 6.9 + 3.9 + 4 = 33.1 · Decision use: Balanced evidence: keep at normal research priority and require another comparable period before raising conviction. | ||||||
Missing observations are not scored as bad. Their missing weight lowers confidence and pulls the final score toward neutral. Financial companies use P/BV÷ROE and asset quality; PEG, industrial OPM and ROCE are excluded. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led NIFTY 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step curve the sector itself is placed on — basing, turning, breaking out, leader, fading, asleep — read from how many weeks running it has led NIFTY 500 and whether that lead is widening or shrinking. It describes where the PRICE stands, not the earnings trajectory and not a recommendation, and it is left blank for a company whose weekly history is too short or too stale to read.
Frequently asked questions
What is Cholamandalam Investment & Finance Company Ltd's share price today?
Cholamandalam Investment & Finance Company Ltd trades at ₹1,850, +30.0% over the past year. The company is valued at ₹1,57,733 Cr. The stock sits at 100% of its 52-week range of ₹1,416–₹1,850, +13.2% versus its 200-day average. On the tape, the price is in a confirmed uptrend, 5 weeks in. — as of 31 July 2026.
What were Cholamandalam Investment & Finance Company Ltd's latest quarterly results?
Cholamandalam Investment & Finance Company Ltd reported total income of ₹8,856 Cr and net profit of ₹1,656 Cr for the Jun 26 quarter. Income rose 21.9% and profit rose 45.5% year on year. Earnings per share were ₹19.43. The net margin was 18.7%, 3.0 pp higher than a year earlier. — as of 31 July 2026.
What is Cholamandalam Investment & Finance Company Ltd's revenue?
Cholamandalam Investment & Finance Company Ltd reported revenue of ₹8,856 Cr in the Jun 26 quarter, +21.9% year on year. For the full FY26 fiscal year, revenue was ₹31,120 Cr (+20.2%). Over the last 10 years revenue compounded at 22.1% a year. — as of 31 July 2026.
What is Cholamandalam Investment & Finance Company Ltd's profit?
Cholamandalam Investment & Finance Company Ltd earned ₹1,656 Cr of net profit in the Jun 26 quarter, +45.5% year on year — the 11th straight quarter of growth. Full-year FY26 profit was ₹5,233 Cr. The net margin ran 18.7% in the latest quarter. — as of 31 July 2026.
What is Cholamandalam Investment & Finance Company Ltd's market cap?
Cholamandalam Investment & Finance Company Ltd's market capitalisation is ₹1,57,733 Cr at a share price of ₹1,850. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 31 July 2026.
What is Cholamandalam Investment & Finance Company Ltd's P/BV ratio?
Cholamandalam Investment & Finance Company Ltd trades at a P/BV of 5.2×, at the 61st percentile of its own 10-year range, against a long-run median of 4.7×. This is a comparison with the stock's own history, not a value call — as of 31 July 2026.
Does Cholamandalam Investment & Finance Company Ltd pay a dividend?
Yes — Cholamandalam Investment & Finance Company Ltd's dividend payout was 3% of profit in FY26, and it recorded a payout in each of its last 13 reported fiscal years. This page holds the payout ratio, not a per-share amount. — as of 31 July 2026.
Is Cholamandalam Investment & Finance Company Ltd overvalued?
On its own history, Cholamandalam Investment & Finance Company Ltd looks mid-range against its own history: its P/BV of 5.2× sits at the 61st percentile of its 10-year range (long-run median 4.7×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 31 July 2026.
Is Cholamandalam Investment & Finance Company Ltd growing?
Yes — Cholamandalam Investment & Finance Company Ltd is growing: latest-quarter revenue +21.9% year on year, profit +45.5%, and the the net margin +3.0 pp at 18.7%. The 10-year compound rates are 22.1% (revenue) and 24.7% (profit). The earnings engine currently reads: improving — as of 31 July 2026.
How is Cholamandalam Investment & Finance Company Ltd performing?
Cholamandalam Investment & Finance Company Ltd is in a confirmed uptrend, 5 weeks in. Its latest quarter's income rose 21.9% and profit rose 45.5% year on year. Against the NIFTY 500 it has been ahead on a trailing-13-week view for 11 weeks. — as of 31 July 2026.
What stage is Cholamandalam Investment & Finance Company Ltd in?
Consistent — revenue, profit and EPS growth have stayed positive through the window, with ROE at 18.9% and holding. The read comes from the last 12 quarters of growth (revenue growth +19.6% latest, profit growth +29.1% latest, eps growth +28.0% latest) plus the ROE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 31 July 2026.
Is Cholamandalam Investment & Finance Company Ltd in an uptrend?
Yes — the price is in a confirmed uptrend (week 5 of stage 2), trading +13.2% versus its 200-day average and at 100% of its 52-week range. Price stages cycle base → advance → top → decline, and the stage names where this stock sits in that cycle — as of 31 July 2026.
Is Cholamandalam Investment & Finance Company Ltd beating the market?
On recent form, yes — Cholamandalam Investment & Finance Company Ltd has been ahead of the NIFTY 500 on a trailing-13-week view for 11 straight weeks, the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 10.4 years the stock moved +1,280% against the NIFTY 500's +276% — ahead of the index over the full window. — as of 31 July 2026.
Will Cholamandalam Investment & Finance Company Ltd's share price go up?
This page publishes no price forecast for Cholamandalam Investment & Finance Company Ltd. What it measures instead: the share price is ₹1,850, the price is in a confirmed uptrend 5 weeks in. Its P/BV of 5.2× sits at the 61st percentile of its own 10-year range. — as of 31 July 2026.
Who owns Cholamandalam Investment & Finance Company Ltd?
Promoters hold 49.2% of Cholamandalam Investment & Finance Company Ltd, foreign institutions 24.5%, domestic institutions 20.6% and the public 5.7% (latest quarter). The biggest move on the register over the last two years: Domestic institutions added 3.8 points over 8 quarters. — as of 31 July 2026.
Is Cholamandalam Investment & Finance Company Ltd's loan book healthy?
We do not hold quarterly loan-book quality numbers for Cholamandalam Investment & Finance Company Ltd, so this page says that plainly. The cleanest available reads are revenue growth (+20.2% in FY26) and the net margin on it (18.7%) — as of 31 July 2026.
Where is Cholamandalam Investment & Finance Company Ltd in its business cycle?
Cholamandalam Investment & Finance Company Ltd's FY26 net margin was 16.8%, against a 13-year band of 11.2%–21.2%: mid-band by its own history — neither the peak that precedes mean-reversion nor the trough that precedes recovery. The latest quarter ran 18.7%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 31 July 2026.
What could break the Cholamandalam Investment & Finance Company Ltd story?
The sharpest disagreement: Foreign institutions moved −2.2 points over 8 quarters while the operating story went the other way — someone close to the numbers is not convinced. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 31 July 2026.
Is Cholamandalam Investment & Finance Company Ltd a stock worth studying right now?
This is not investment advice. The machine read: Cholamandalam Investment & Finance Company Ltd compounds quietly. Returns above 15% and growth without drama — priced like it. The sharpest open question: whether the register turns back in the story’s favour. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 31 July 2026.